Advent to sell generic drugmaker Zentiva to GTCR
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Subscribe To Our Newsletter & Stay Updated